Incorporation technical risk in compound real option models to value a pharmaceutical R&D licensing opportunity

D. Cassimon; M. De Backer; P. J. Engelen; M. Van Wouwe; V. Yordanov

Year of publication:	2011
Authors:	Cassimon, Danny ; De Backer, Manu ; Engelen, Peter-Jan ; Van Wouwe, Martine ; Yordanov, V.
Published in:	Research policy : policy, management and economic studies of science, technology and innovation. - Amsterdam [u.a.] : Elsevier, ISSN 0048-7333, ZDB-ID 121149-3. - Vol. 40.2011, 9, p. 1200-1216
Subject:	Realoptionsansatz \| Real options analysis \| Theorie \| Theory \| Pharmaindustrie \| Pharmaceutical industry \| Lizenz \| Licence \| Risiko \| Risk \| Arzneimittel \| Pharmaceuticals

Check Google Scholar |

More access options

In libraries world-wide (WorldCat)

In German libraries (KVK)

Which error do you want to report?

Report: URL of this record is broken

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: Addition of an URL to that resource

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: The language(s) of that resource is/are…

Please note: Required language not in the list? Please use comment field

Report: Addition of an identifier to that resource

Report: report typo

Report: Add statement

Report: Add keywords

Please use the commentary box to describe other errors

Would you like to receive a feedback?

Commentary

Please type the code from the image

For general questions please use this address.

Persistent link: https://www.econbiz.de/10009379464

A service of the